# SPNT — SiriusPoint Ltd · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** SPNT  
**Sources:** 19  
**Published:** 2026-10-06  
**Canonical:** https://app.k3vl4r.com/research/deep-research-spnt-siriuspoint-ltd-catalysts-narrative-risks-6321

---

# SiriusPoint Ltd. (NYSE: SPNT) — Point-in-Time Research Snapshot

**As of 2026-10-06. This is a research summary, not investment advice.**

## Profile
SiriusPoint is a Bermuda-headquartered specialty underwriter of property & casualty insurance and reinsurance, operating on the NYSE with segments spanning Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty [[14]](https://investors.siriuspt.com/overview/default.aspx), [[16]](https://www.cnn.com/markets/stocks/SPNT), [[18]](https://stockanalysis.com/stocks/spnt/). As of the date, it is a mid-cap stock (~$2.85 billion market cap) trading near the top of its 52-week range ($17.39–$26.50), with a price around $24.6, a TTM P/E near 6x, a forward P/E of ~9.1x, and a beta of 0.59 [[13]](https://finance.yahoo.com/quote/SPNT/), [[18]](https://stockanalysis.com/stocks/spnt/).

## Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-spnt-siriuspoint-ltd-catalysts-narrative-risks-6321 (free to sign up)._